CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Primary Prevention of Heart Failure in Women Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors

Original Research2020 Dec 24;S2213-1779(20)30585-0.

JOURNAL:JACC Heart Fail . Article Link

Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure

KN Bachmann, DK Gupta , M Xu et al. Keywords: B-type natriuretic peptide; BNP; electronic health record; natriuretic peptide; natriuretic peptide deficiency

Full Text PDF